English
简体中文
Total: £ 56.28
Published Date: 2026-02-27 | Pages: 112 | Tables: 118 | Medical Devices & Consumables
The global AI Medical Imaging Software for Lung Diseases market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
AI medical imaging software for lung diseases leverages artificial intelligence to automatically analyze medical images such as CT scans and X-rays, assisting physicians in detecting and diagnosing various lung conditions, including lung nodules, pneumonia, and chronic obstructive pulmonary disease (COPD). The software utilizes deep learning algorithms to identify abnormalities and offers precise localization and classification suggestions, enhancing diagnostic accuracy and efficiency. It also supports early disease detection and aids in clinical decision-making, reducing the workload on healthcare professionals.
The North American market for AI Medical Imaging Software for Lung Diseases is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The Asia-Pacific market for AI Medical Imaging Software for Lung Diseases is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The global market for AI Medical Imaging Software for Lung Diseases in Hospital is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 to 2032.
Major global companies of AI Medical Imaging Software for Lung Diseases include Siemens, Riverain Technologies, Deepwise, Shukun Technology, Infervision Medical, United-Imaging, Yizhun Intelligent, VoxelCloud, Fosun Aitrox, Huiying Medical, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.
This report delivers a comprehensive overview of the global AI Medical Imaging Software for Lung Diseases market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding AI Medical Imaging Software for Lung Diseases. The AI Medical Imaging Software for Lung Diseases market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global AI Medical Imaging Software for Lung Diseases market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist AI Medical Imaging Software for Lung Diseases manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
Siemens
Riverain Technologies
Deepwise
Shukun Technology
Infervision Medical
United-Imaging
Yizhun Intelligent
VoxelCloud
Fosun Aitrox
Huiying Medical
BioMind
Segment by Type
Pulmonary Nodules
Pneumonia
Other
Segment by Application
Hospital
Clinic
By Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia & New Zealand
Rest of Asia
Europe
Germany
France
U.K.
Italy
Ireland
Russia
Rest of Europe
Latin America
Mexico
Brazil
Argentina
Rest of Latin America
Middle East & Africa
Israel
United Arab Emirates (UAE)
Saudi Arabia
Rest of MEA
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for AI Medical Imaging Software for Lung Diseases companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global AI Medical Imaging Software for Lung Diseases Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 Pulmonary Nodules
1.2.3 Pneumonia
1.2.4 Other
1.3 Market by Application
1.3.1 Global AI Medical Imaging Software for Lung Diseases Market Growth by Application: 2021 vs 2025 vs 2032
1.3.2 Hospital
1.3.3 Clinic
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global AI Medical Imaging Software for Lung Diseases Market Perspective (2021–2032)
2.2 Global AI Medical Imaging Software for Lung Diseases Growth Trends by Region
2.2.1 Global AI Medical Imaging Software for Lung Diseases Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 AI Medical Imaging Software for Lung Diseases Historic Market Size by Region (2021–2026)
2.2.3 AI Medical Imaging Software for Lung Diseases Forecasted Market Size by Region (2027–2032)
2.3 AI Medical Imaging Software for Lung Diseases Market Dynamics
2.3.1 AI Medical Imaging Software for Lung Diseases Industry Trends
2.3.2 AI Medical Imaging Software for Lung Diseases Market Drivers
2.3.3 AI Medical Imaging Software for Lung Diseases Market Challenges
2.3.4 AI Medical Imaging Software for Lung Diseases Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top AI Medical Imaging Software for Lung Diseases Players by Revenue
3.1.1 Global Top AI Medical Imaging Software for Lung Diseases Players by Revenue (2021–2026)
3.1.2 Global AI Medical Imaging Software for Lung Diseases Revenue Market Share by Players (2021–2026)
3.2 Global Top AI Medical Imaging Software for Lung Diseases Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by AI Medical Imaging Software for Lung Diseases Revenue
3.4 Global AI Medical Imaging Software for Lung Diseases Market Concentration Ratio
3.4.1 Global AI Medical Imaging Software for Lung Diseases Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by AI Medical Imaging Software for Lung Diseases Revenue in 2025
3.5 Global Key Players of AI Medical Imaging Software for Lung Diseases Head Offices and Areas Served
3.6 Global Key Players of AI Medical Imaging Software for Lung Diseases, Products and Applications
3.7 Global Key Players of AI Medical Imaging Software for Lung Diseases, Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans
4 AI Medical Imaging Software for Lung Diseases Breakdown Data by Type
4.1 Global AI Medical Imaging Software for Lung Diseases Historic Market Size by Type (2021–2026)
4.2 Global AI Medical Imaging Software for Lung Diseases Forecasted Market Size by Type (2027–2032)
5 AI Medical Imaging Software for Lung Diseases Breakdown Data by Application
5.1 Global AI Medical Imaging Software for Lung Diseases Historic Market Size by Application (2021–2026)
5.2 Global AI Medical Imaging Software for Lung Diseases Forecasted Market Size by Application (2027–2032)
6 North America
6.1 North America AI Medical Imaging Software for Lung Diseases Market Size (2021–2032)
6.2 North America AI Medical Imaging Software for Lung Diseases Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America AI Medical Imaging Software for Lung Diseases Market Size by Country (2021–2026)
6.4 North America AI Medical Imaging Software for Lung Diseases Market Size by Country (2027–2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe AI Medical Imaging Software for Lung Diseases Market Size (2021–2032)
7.2 Europe AI Medical Imaging Software for Lung Diseases Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe AI Medical Imaging Software for Lung Diseases Market Size by Country (2021–2026)
7.4 Europe AI Medical Imaging Software for Lung Diseases Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific AI Medical Imaging Software for Lung Diseases Market Size (2021–2032)
8.2 Asia-Pacific AI Medical Imaging Software for Lung Diseases Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific AI Medical Imaging Software for Lung Diseases Market Size by Region (2021–2026)
8.4 Asia-Pacific AI Medical Imaging Software for Lung Diseases Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America AI Medical Imaging Software for Lung Diseases Market Size (2021–2032)
9.2 Latin America AI Medical Imaging Software for Lung Diseases Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America AI Medical Imaging Software for Lung Diseases Market Size by Country (2021–2026)
9.4 Latin America AI Medical Imaging Software for Lung Diseases Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa AI Medical Imaging Software for Lung Diseases Market Size (2021–2032)
10.2 Middle East & Africa AI Medical Imaging Software for Lung Diseases Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa AI Medical Imaging Software for Lung Diseases Market Size by Country (2021–2026)
10.4 Middle East & Africa AI Medical Imaging Software for Lung Diseases Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Siemens
11.1.1 Siemens Company Details
11.1.2 Siemens Business Overview
11.1.3 Siemens AI Medical Imaging Software for Lung Diseases Introduction
11.1.4 Siemens Revenue in AI Medical Imaging Software for Lung Diseases Business (2021–2026)
11.1.5 Siemens Recent Development
11.2 Riverain Technologies
11.2.1 Riverain Technologies Company Details
11.2.2 Riverain Technologies Business Overview
11.2.3 Riverain Technologies AI Medical Imaging Software for Lung Diseases Introduction
11.2.4 Riverain Technologies Revenue in AI Medical Imaging Software for Lung Diseases Business (2021–2026)
11.2.5 Riverain Technologies Recent Development
11.3 Deepwise
11.3.1 Deepwise Company Details
11.3.2 Deepwise Business Overview
11.3.3 Deepwise AI Medical Imaging Software for Lung Diseases Introduction
11.3.4 Deepwise Revenue in AI Medical Imaging Software for Lung Diseases Business (2021–2026)
11.3.5 Deepwise Recent Development
11.4 Shukun Technology
11.4.1 Shukun Technology Company Details
11.4.2 Shukun Technology Business Overview
11.4.3 Shukun Technology AI Medical Imaging Software for Lung Diseases Introduction
11.4.4 Shukun Technology Revenue in AI Medical Imaging Software for Lung Diseases Business (2021–2026)
11.4.5 Shukun Technology Recent Development
11.5 Infervision Medical
11.5.1 Infervision Medical Company Details
11.5.2 Infervision Medical Business Overview
11.5.3 Infervision Medical AI Medical Imaging Software for Lung Diseases Introduction
11.5.4 Infervision Medical Revenue in AI Medical Imaging Software for Lung Diseases Business (2021–2026)
11.5.5 Infervision Medical Recent Development
11.6 United-Imaging
11.6.1 United-Imaging Company Details
11.6.2 United-Imaging Business Overview
11.6.3 United-Imaging AI Medical Imaging Software for Lung Diseases Introduction
11.6.4 United-Imaging Revenue in AI Medical Imaging Software for Lung Diseases Business (2021–2026)
11.6.5 United-Imaging Recent Development
11.7 Yizhun Intelligent
11.7.1 Yizhun Intelligent Company Details
11.7.2 Yizhun Intelligent Business Overview
11.7.3 Yizhun Intelligent AI Medical Imaging Software for Lung Diseases Introduction
11.7.4 Yizhun Intelligent Revenue in AI Medical Imaging Software for Lung Diseases Business (2021–2026)
11.7.5 Yizhun Intelligent Recent Development
11.8 VoxelCloud
11.8.1 VoxelCloud Company Details
11.8.2 VoxelCloud Business Overview
11.8.3 VoxelCloud AI Medical Imaging Software for Lung Diseases Introduction
11.8.4 VoxelCloud Revenue in AI Medical Imaging Software for Lung Diseases Business (2021–2026)
11.8.5 VoxelCloud Recent Development
11.9 Fosun Aitrox
11.9.1 Fosun Aitrox Company Details
11.9.2 Fosun Aitrox Business Overview
11.9.3 Fosun Aitrox AI Medical Imaging Software for Lung Diseases Introduction
11.9.4 Fosun Aitrox Revenue in AI Medical Imaging Software for Lung Diseases Business (2021–2026)
11.9.5 Fosun Aitrox Recent Development
11.10 Huiying Medical
11.10.1 Huiying Medical Company Details
11.10.2 Huiying Medical Business Overview
11.10.3 Huiying Medical AI Medical Imaging Software for Lung Diseases Introduction
11.10.4 Huiying Medical Revenue in AI Medical Imaging Software for Lung Diseases Business (2021–2026)
11.10.5 Huiying Medical Recent Development
11.11 BioMind
11.11.1 BioMind Company Details
11.11.2 BioMind Business Overview
11.11.3 BioMind AI Medical Imaging Software for Lung Diseases Introduction
11.11.4 BioMind Revenue in AI Medical Imaging Software for Lung Diseases Business (2021–2026)
11.11.5 BioMind Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global AI Medical Imaging Software for Lung Diseases Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
Table 2. Key Players of Pulmonary Nodules
Table 3. Key Players of Pneumonia
Table 4. Key Players of Other
Table 5. Global AI Medical Imaging Software for Lung Diseases Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
Table 6. Global AI Medical Imaging Software for Lung Diseases Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 7. Global AI Medical Imaging Software for Lung Diseases Market Size by Region (US$ Million), 2021–2026
Table 8. Global AI Medical Imaging Software for Lung Diseases Market Share by Region (2021–2026)
Table 9. Global AI Medical Imaging Software for Lung Diseases Forecasted Market Size by Region (US$ Million), 2027–2032
Table 10. Global AI Medical Imaging Software for Lung Diseases Market Share by Region (2027–2032)
Table 11. AI Medical Imaging Software for Lung Diseases Market Trends
Table 12. AI Medical Imaging Software for Lung Diseases Market Drivers
Table 13. AI Medical Imaging Software for Lung Diseases Market Challenges
Table 14. AI Medical Imaging Software for Lung Diseases Market Restraints
Table 15. Global AI Medical Imaging Software for Lung Diseases Revenue by Players (US$ Million), 2021–2026
Table 16. Global AI Medical Imaging Software for Lung Diseases Market Share by Players (2021–2026)
Table 17. Global Top AI Medical Imaging Software for Lung Diseases Players by Tier (Tier 1, Tier 2, and Tier 3), based on AI Medical Imaging Software for Lung Diseases Revenue, 2025
Table 18. Ranking of Global Top AI Medical Imaging Software for Lung Diseases Companies by Revenue (US$ Million) in 2025
Table 19. Global 5 Largest Players Market Share by AI Medical Imaging Software for Lung Diseases Revenue (CR5 and HHI), 2021–2026
Table 20. Global Key Players of AI Medical Imaging Software for Lung Diseases, Headquarters and Area Served
Table 21. Global Key Players of AI Medical Imaging Software for Lung Diseases, Products and Applications
Table 22. Global Key Players of AI Medical Imaging Software for Lung Diseases, Date of General Availability (GA)
Table 23. Mergers and Acquisitions, Expansion Plans
Table 24. Global AI Medical Imaging Software for Lung Diseases Market Size by Type (US$ Million), 2021–2026
Table 25. Global AI Medical Imaging Software for Lung Diseases Revenue Market Share by Type (2021–2026)
Table 26. Global AI Medical Imaging Software for Lung Diseases Forecasted Market Size by Type (US$ Million), 2027–2032
Table 27. Global AI Medical Imaging Software for Lung Diseases Revenue Market Share by Type (2027–2032)
Table 28. Global AI Medical Imaging Software for Lung Diseases Market Size by Application (US$ Million), 2021–2026
Table 29. Global AI Medical Imaging Software for Lung Diseases Revenue Market Share by Application (2021–2026)
Table 30. Global AI Medical Imaging Software for Lung Diseases Forecasted Market Size by Application (US$ Million), 2027–2032
Table 31. Global AI Medical Imaging Software for Lung Diseases Revenue Market Share by Application (2027–2032)
Table 32. North America AI Medical Imaging Software for Lung Diseases Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 33. North America AI Medical Imaging Software for Lung Diseases Market Size by Country (US$ Million), 2021–2026
Table 34. North America AI Medical Imaging Software for Lung Diseases Market Size by Country (US$ Million), 2027–2032
Table 35. Europe AI Medical Imaging Software for Lung Diseases Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 36. Europe AI Medical Imaging Software for Lung Diseases Market Size by Country (US$ Million), 2021–2026
Table 37. Europe AI Medical Imaging Software for Lung Diseases Market Size by Country (US$ Million), 2027–2032
Table 38. Asia-Pacific AI Medical Imaging Software for Lung Diseases Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
Table 39. Asia-Pacific AI Medical Imaging Software for Lung Diseases Market Size by Region (US$ Million), 2021–2026
Table 40. Asia-Pacific AI Medical Imaging Software for Lung Diseases Market Size by Region (US$ Million), 2027–2032
Table 41. Latin America AI Medical Imaging Software for Lung Diseases Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 42. Latin America AI Medical Imaging Software for Lung Diseases Market Size by Country (US$ Million), 2021–2026
Table 43. Latin America AI Medical Imaging Software for Lung Diseases Market Size by Country (US$ Million), 2027–2032
Table 44. Middle East & Africa AI Medical Imaging Software for Lung Diseases Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 45. Middle East & Africa AI Medical Imaging Software for Lung Diseases Market Size by Country (US$ Million), 2021–2026
Table 46. Middle East & Africa AI Medical Imaging Software for Lung Diseases Market Size by Country (US$ Million), 2027–2032
Table 47. Siemens Company Details
Table 48. Siemens Business Overview
Table 49. Siemens AI Medical Imaging Software for Lung Diseases Product
Table 50. Siemens Revenue in AI Medical Imaging Software for Lung Diseases Business (US$ Million), 2021–2026
Table 51. Siemens Recent Development
Table 52. Riverain Technologies Company Details
Table 53. Riverain Technologies Business Overview
Table 54. Riverain Technologies AI Medical Imaging Software for Lung Diseases Product
Table 55. Riverain Technologies Revenue in AI Medical Imaging Software for Lung Diseases Business (US$ Million), 2021–2026
Table 56. Riverain Technologies Recent Development
Table 57. Deepwise Company Details
Table 58. Deepwise Business Overview
Table 59. Deepwise AI Medical Imaging Software for Lung Diseases Product
Table 60. Deepwise Revenue in AI Medical Imaging Software for Lung Diseases Business (US$ Million), 2021–2026
Table 61. Deepwise Recent Development
Table 62. Shukun Technology Company Details
Table 63. Shukun Technology Business Overview
Table 64. Shukun Technology AI Medical Imaging Software for Lung Diseases Product
Table 65. Shukun Technology Revenue in AI Medical Imaging Software for Lung Diseases Business (US$ Million), 2021–2026
Table 66. Shukun Technology Recent Development
Table 67. Infervision Medical Company Details
Table 68. Infervision Medical Business Overview
Table 69. Infervision Medical AI Medical Imaging Software for Lung Diseases Product
Table 70. Infervision Medical Revenue in AI Medical Imaging Software for Lung Diseases Business (US$ Million), 2021–2026
Table 71. Infervision Medical Recent Development
Table 72. United-Imaging Company Details
Table 73. United-Imaging Business Overview
Table 74. United-Imaging AI Medical Imaging Software for Lung Diseases Product
Table 75. United-Imaging Revenue in AI Medical Imaging Software for Lung Diseases Business (US$ Million), 2021–2026
Table 76. United-Imaging Recent Development
Table 77. Yizhun Intelligent Company Details
Table 78. Yizhun Intelligent Business Overview
Table 79. Yizhun Intelligent AI Medical Imaging Software for Lung Diseases Product
Table 80. Yizhun Intelligent Revenue in AI Medical Imaging Software for Lung Diseases Business (US$ Million), 2021–2026
Table 81. Yizhun Intelligent Recent Development
Table 82. VoxelCloud Company Details
Table 83. VoxelCloud Business Overview
Table 84. VoxelCloud AI Medical Imaging Software for Lung Diseases Product
Table 85. VoxelCloud Revenue in AI Medical Imaging Software for Lung Diseases Business (US$ Million), 2021–2026
Table 86. VoxelCloud Recent Development
Table 87. Fosun Aitrox Company Details
Table 88. Fosun Aitrox Business Overview
Table 89. Fosun Aitrox AI Medical Imaging Software for Lung Diseases Product
Table 90. Fosun Aitrox Revenue in AI Medical Imaging Software for Lung Diseases Business (US$ Million), 2021–2026
Table 91. Fosun Aitrox Recent Development
Table 92. Huiying Medical Company Details
Table 93. Huiying Medical Business Overview
Table 94. Huiying Medical AI Medical Imaging Software for Lung Diseases Product
Table 95. Huiying Medical Revenue in AI Medical Imaging Software for Lung Diseases Business (US$ Million), 2021–2026
Table 96. Huiying Medical Recent Development
Table 97. BioMind Company Details
Table 98. BioMind Business Overview
Table 99. BioMind AI Medical Imaging Software for Lung Diseases Product
Table 100. BioMind Revenue in AI Medical Imaging Software for Lung Diseases Business (US$ Million), 2021–2026
Table 101. BioMind Recent Development
Table 102. Research Programs/Design for This Report
Table 103. Key Data Information from Secondary Sources
Table 104. Key Data Information from Primary Sources
Table 105. Authors List of This Report
List of Figures
Figure 1. AI Medical Imaging Software for Lung Diseases Picture
Figure 2. Global AI Medical Imaging Software for Lung Diseases Market Size Comparison by Type (US$ Million), 2021–2032
Figure 3. Global AI Medical Imaging Software for Lung Diseases Market Share by Type: 2025 vs 2032
Figure 4. Pulmonary Nodules Features
Figure 5. Pneumonia Features
Figure 6. Other Features
Figure 7. Global AI Medical Imaging Software for Lung Diseases Market Size by Application (US$ Million), 2021–2032
Figure 8. Global AI Medical Imaging Software for Lung Diseases Market Share by Application: 2025 vs 2032
Figure 9. Hospital Case Studies
Figure 10. Clinic Case Studies
Figure 11. AI Medical Imaging Software for Lung Diseases Report Years Considered
Figure 12. Global AI Medical Imaging Software for Lung Diseases Market Size (US$ Million), Year-over-Year: 2021–2032
Figure 13. Global AI Medical Imaging Software for Lung Diseases Market Size, (US$ Million), 2021 vs 2025 vs 2032
Figure 14. Global AI Medical Imaging Software for Lung Diseases Market Share by Region: 2025 vs 2032
Figure 15. Global AI Medical Imaging Software for Lung Diseases Market Share by Players in 2025
Figure 16. Global AI Medical Imaging Software for Lung Diseases Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 17. The Top 10 and 5 Players Market Share by AI Medical Imaging Software for Lung Diseases Revenue in 2025
Figure 18. North America AI Medical Imaging Software for Lung Diseases Market Size YoY Growth (US$ Million), 2021–2032
Figure 19. North America AI Medical Imaging Software for Lung Diseases Market Share by Country (2021–2032)
Figure 20. United States AI Medical Imaging Software for Lung Diseases Market Size YoY Growth (US$ Million), 2021–2032
Figure 21. Canada AI Medical Imaging Software for Lung Diseases Market Size YoY Growth (US$ Million), 2021–2032
Figure 22. Europe AI Medical Imaging Software for Lung Diseases Market Size YoY Growth (US$ Million), 2021–2032
Figure 23. Europe AI Medical Imaging Software for Lung Diseases Market Share by Country (2021–2032)
Figure 24. Germany AI Medical Imaging Software for Lung Diseases Market Size YoY Growth (US$ Million), 2021–2032
Figure 25. France AI Medical Imaging Software for Lung Diseases Market Size YoY Growth (US$ Million), 2021–2032
Figure 26. U.K. AI Medical Imaging Software for Lung Diseases Market Size YoY Growth (US$ Million), 2021–2032
Figure 27. Italy AI Medical Imaging Software for Lung Diseases Market Size YoY Growth (US$ Million), 2021–2032
Figure 28. Russia AI Medical Imaging Software for Lung Diseases Market Size YoY Growth (US$ Million), 2021–2032
Figure 29. Ireland AI Medical Imaging Software for Lung Diseases Market Size YoY Growth (US$ Million), 2021–2032
Figure 30. Asia-Pacific AI Medical Imaging Software for Lung Diseases Market Size YoY Growth (US$ Million), 2021–2032
Figure 31. Asia-Pacific AI Medical Imaging Software for Lung Diseases Market Share by Region (2021–2032)
Figure 32. China AI Medical Imaging Software for Lung Diseases Market Size YoY Growth (US$ Million), 2021–2032
Figure 33. Japan AI Medical Imaging Software for Lung Diseases Market Size YoY Growth (US$ Million), 2021–2032
Figure 34. South Korea AI Medical Imaging Software for Lung Diseases Market Size YoY Growth (US$ Million), 2021–2032
Figure 35. Southeast Asia AI Medical Imaging Software for Lung Diseases Market Size YoY Growth (US$ Million), 2021–2032
Figure 36. India AI Medical Imaging Software for Lung Diseases Market Size YoY Growth (US$ Million), 2021–2032
Figure 37. Australia & New Zealand AI Medical Imaging Software for Lung Diseases Market Size YoY Growth (US$ Million), 2021–2032
Figure 38. Latin America AI Medical Imaging Software for Lung Diseases Market Size YoY Growth (US$ Million), 2021–2032
Figure 39. Latin America AI Medical Imaging Software for Lung Diseases Market Share by Country (2021–2032)
Figure 40. Mexico AI Medical Imaging Software for Lung Diseases Market Size YoY Growth (US$ Million), 2021–2032
Figure 41. Brazil AI Medical Imaging Software for Lung Diseases Market Size YoY Growth (US$ Million), 2021–2032
Figure 42. Middle East & Africa AI Medical Imaging Software for Lung Diseases Market Size YoY Growth (US$ Million), 2021–2032
Figure 43. Middle East & Africa AI Medical Imaging Software for Lung Diseases Market Share by Country (2021–2032)
Figure 44. Israel AI Medical Imaging Software for Lung Diseases Market Size YoY Growth (US$ Million), 2021–2032
Figure 45. Saudi Arabia AI Medical Imaging Software for Lung Diseases Market Size YoY Growth (US$ Million), 2021–2032
Figure 46. UAE AI Medical Imaging Software for Lung Diseases Market Size YoY Growth (US$ Million), 2021–2032
Figure 47. Siemens Revenue Growth Rate in AI Medical Imaging Software for Lung Diseases Business (2021–2026)
Figure 48. Riverain Technologies Revenue Growth Rate in AI Medical Imaging Software for Lung Diseases Business (2021–2026)
Figure 49. Deepwise Revenue Growth Rate in AI Medical Imaging Software for Lung Diseases Business (2021–2026)
Figure 50. Shukun Technology Revenue Growth Rate in AI Medical Imaging Software for Lung Diseases Business (2021–2026)
Figure 51. Infervision Medical Revenue Growth Rate in AI Medical Imaging Software for Lung Diseases Business (2021–2026)
Figure 52. United-Imaging Revenue Growth Rate in AI Medical Imaging Software for Lung Diseases Business (2021–2026)
Figure 53. Yizhun Intelligent Revenue Growth Rate in AI Medical Imaging Software for Lung Diseases Business (2021–2026)
Figure 54. VoxelCloud Revenue Growth Rate in AI Medical Imaging Software for Lung Diseases Business (2021–2026)
Figure 55. Fosun Aitrox Revenue Growth Rate in AI Medical Imaging Software for Lung Diseases Business (2021–2026)
Figure 56. Huiying Medical Revenue Growth Rate in AI Medical Imaging Software for Lung Diseases Business (2021–2026)
Figure 57. BioMind Revenue Growth Rate in AI Medical Imaging Software for Lung Diseases Business (2021–2026)
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed
